Sanofi faces class-action lawsuit over epilepsy drug side effects
“A French court has ruled that families of children who suffered side effects from the epilepsy medicine Depakine can join in a class-action lawsuit against drug maker Sanofi,” reported Bloomberg News on January 5. The company should have warned of the risk of birth defects for pregnant women taking the medicine as early as 1984, a Paris court said. Instead, it only took those steps in 2003, calling the product that was sold for decades “defective”. Depakine is a powerful anti-epileptic drug that is on the World Health Organisation’s list of essential medicines, but it has been blamed for neuro-development problems in tens of thousands of children in a long-running court case in Sanofi’s home market.